Tag Archives: NASDAQ:OPHT

What Did This CEO Just Do with Personal Shares of Ophthotech Corp (NASDAQ: OPHT)?

Today, the President & CEO of Ophthotech Corp (OPHT – Research Report), Glenn Sblendorio, sold shares of OPHT for $9,887. See today’s analyst top recommended stocks >> OPHT’s market cap is $59.2M and the company has a P/E ratio of

Chardan Capital Sticks to Its Hold Rating for Ophthotech Corp (OPHT)

In a report released today, Gbola Amusa from Chardan Capital reiterated a Hold rating on Ophthotech Corp (NASDAQ: OPHT), with a price target of $4. The company’s shares closed yesterday at $2.46, close to its 52-week low of $2.25. Amusa

Ophthotech Corp Receives a Hold from Chardan Capital

In a report issued on June 8, Gbola Amusa from Chardan Capital assigned a Hold rating to Ophthotech Corp (NASDAQ: OPHT), with a price target of $4. The company’s shares opened today at $3.11. Amusa noted: “We understand previous attempts

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ophthotech Corp (NASDAQ: OPHT) and NuVasive (NASDAQ: NUVA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ophthotech Corp (NASDAQ: OPHT) and NuVasive (NASDAQ: NUVA). Ophthotech Corp (NASDAQ: OPHT) Stifel Nicolaus analyst Stephen Willey reiterated a Hold rating on Ophthotech Corp (NASDAQ:

Chardan Capital Keeps Their Hold Rating on Ophthotech Corp

Chardan Capital analyst Gbola Amusa reiterated a Hold rating on Ophthotech Corp (NASDAQ: OPHT) yesterday and set a price target of $3. The company’s shares closed yesterday at $2.71, close to its 52-week high of $65.96. According to TipRanks.com, Amusa

A Major Shareholder at Ophthotech Corp (NASDAQ: OPHT) is Selling Shares

Today, a Major Shareholder at Ophthotech Corp (NASDAQ: OPHT), A S Novo, sold shares of OPHT for $17.59M. The company has a one year high of $80 and a one year low of $4.53. Currently, Ophthotech Corp has an average